Parenteral Drug (India) share news and announcements

BSE: 524689Pharmaceuticals & Biotechnology

Trading suspended since 3 Feb 2025

Last traded ₹2.90 on 21 Aug 2023

Parenteral Drug (India) routine notices

112 filed, newest first. Page 2 of 3.

Oct 2020
- 23 Oct · Routine
  Parenteral Drugs (India) Limited hereby submits compliance certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September 2020. (opens in a new tab)
Aug 2020
- 29 Aug · Routine
  Newspaper Publication regarding Notice of 36th Annual General Meeting. (opens in a new tab)
- 29 Aug · Routine
  Parenteral Drugs (India) Limited hereby submits newspaper clippings of Notice for 36th Annual General Meeting published in newspaper. (opens in a new tab)
- 26 Aug · Routine
  Parenteral Drugs (India)Limited hereby submits the newspaper publication of public notice for 36th Annual General Meeting . (opens in a new tab)
- 26 Aug · Routine
  Parenteral Drugs (India) Limited hereby submits newspaper publication of Unaudited Financial Results for the Quarter ended on 30th June, 2020. (opens in a new tab)
- 26 Aug · Routine
  Copy of Newspaper Publication of public notice of 36th Annual General Meeting. (opens in a new tab)
- 26 Aug · Routine
  Copy of Newspaper clippings for Unaudited financial results for the quarter ended 30th June 2020 published pursuant to Regulation of 47 SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015. (opens in a new tab)
- 20 Aug · Routine
  Copy of Newspaper Publication (opens in a new tab)
- 20 Aug · Routine
  Parenteral Drugs (India) Limited hereby submits clippings of newspaper notice published pursuant to Regulation 47 SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 . (opens in a new tab)
Jul 2020
- 30 Jul · Routine
  Copy of Newspaper Publication of Annual Audited Financial Results for the quarter and year ended on 31st March, 2020 published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 30 Jul · Routine
  Parenteral Drugs (India) Limited hereby submits newspaper clippings of Annual Audited Financial Results for the quarter and year ended on 31st March, 2020 published pursuant to Regulation .... (opens in a new tab)
- 29 Jul · Routine
  Parenteral Drugs (India) Limited hereby submits Annual Secretarial Compliance Report received from M/s. Archna Maheshwari and Co., Practicing Company Secretaries, for the financial year .... (opens in a new tab)
- 24 Jul · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
- 24 Jul · Routine
  Parenteral Drugs (India) Limited hereby submits Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th june, 2020. (opens in a new tab)
- 23 Jul · Routine
  Parenteral Drugs (India) Limited hereby submits Clippings of Newspaper Notice published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
Jun 2020
- 30 Jun · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
May 2020
- 26 May · Routine
  Parenteral Drugs hereby submits Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2020 (opens in a new tab)
Feb 2020
- 13 Feb · Routine
  Newspaper clippings of un-audited financial results for the quarter ended December 31, 2019 published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 13 Feb · Routine
  Parenteral Drugs (India) Limited hereby submits newspaper clippings of un-audited financial results for the quarter ended 31st December, 2019 published pursuant to Regulation 47 of SEBI .... (opens in a new tab)
Jan 2020
- 31 Jan · Routine
  Parenteral Drugs (India) Limited hereby submits Clippings of Newspaper Notice published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 18 Jan · Routine
  Parenteral Drugs (India) Limited hereby submits certificate for the Quarter ended December,2019, under regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. (opens in a new tab)
Dec 2019
- 31 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 31 Dec · Routine
  In pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, Parenteral Drugs (India) Limited hereby announces that the trading window for the Equity .... (opens in a new tab)
- 16 Dec · Routine
  Parenteral Drugs (India) Limited hereby intimates information with respect to Loss of Share Certificate. (opens in a new tab)
Oct 2019
- 19 Oct · Routine
  Parenteral Drugs (India) Limited hereby submits Confirmation Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. (opens in a new tab)
Aug 2019
- 13 Aug · Routine
  Parenteral Drugs (India) Limited hereby submits Newspaper Clippings w.r.t. publication of notice in respect to Annual General Meeting. (opens in a new tab)
Jul 2019
- 10 Jul · Routine
  Parenteral Drugs (India) Limited hereby submits Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
- 2 Jul · Routine
  Pareneteral Drugs (India) limited hereby submits information regarding loss of share certificates (opens in a new tab)
Jun 2019
- 29 Jun · Routine
  In pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, Parenteral Drugs (India) Limited hereby announces that the trading window for the Equity Shares of the .... (opens in a new tab)
- 29 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 29 Jun · Routine
  In pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, Parenteral Drugs (India) Limited hereby announces that the trading window for the Equity Shares of the .... (opens in a new tab)
- 1 Jun · Routine
  Annual Secretarial Compliance Report Sr. No. Particulars Details 1 Period .... (opens in a new tab)
May 2019
- 30 May · Routine
  Annual Secretarial Compliance Report Sr. No. Particulars Details 1 Period .... (opens in a new tab)
Apr 2019
- 30 Apr · Routine
  Parenteral Drugs (India) Limited hereby intimate information with respect to Loss of Share Certificate. (opens in a new tab)
- 30 Apr · Routine
  Parenteral Drugs (India) Limited hereby intimate information with respect to Loss of Share Certificate (opens in a new tab)
- 26 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 4 Apr · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 4 Apr · Routine
  In pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, we hereby announces that the trading window for the Equity Shares of the company shall remain close with .... (opens in a new tab)
Mar 2019
- 23 Mar · Routine
  Dear Sir/Ma'am, With reference to the captioned subject, we would like to inform the exchange that the Company has received intimation regarding loss of share certificates and .... (opens in a new tab)
Nov 2016
- 7 Nov · Routine
  Meeting of the Board of Directors of the Company will be held on November 14, 2016, inter alia, to consider the Unaudited (Provisional) .... (opens in a new tab)
Aug 2016
- 5 Aug · Routine
  Meeting of the Board of Directors of the Company will be held on August 12, 2016, inter alia, to consider the Unaudited (Provisional) .... (opens in a new tab)
May 2016
- 23 May · Routine
  As per the provisions of regulation 9 and Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. May 21, 2016 to June 01, 2016 and will open on June 02, 2016 for insiders accordingly. (opens in a new tab)
- 21 May · Routine
  Meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider the Audited Financial Statement ....
Feb 2016
- 4 Feb · Routine
  Meeting of the Board of Directors of the Company will be held on February 13, 2016, inter alia, to consider the unaudited financial results ....
- 4 Feb · Routine
  As per the provisions of regulation 9 and Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company's Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. February 04, 2016 to February 15, 2016 and will open on February 16, 2016 for insiders accordingly. (opens in a new tab)
Dec 2015
- 28 Dec · Routine
  The "Trading Window" of the Company shall remain closed from the date of intimation i.e. December 26, 2015 to January 01, 2016 and will open on January 02, 2016 for insiders accordingly. (opens in a new tab)
Oct 2015
- 31 Oct · Routine
  Board Intimation for Results & Closure of Trading Window (opens in a new tab)
- 31 Oct · Routine
  The "Trading Window" of the Company shall remain closed from October 31, 2015 to November 11, 2015 and will open on November 12, 2015 for insiders accordingly. (opens in a new tab)
Sep 2015
- 22 Sep · Routine
  The "Trading Window' of the Company shall remain closed from September 22, 2015 to October 2, 2015 and will open on October 3, 2015 for insiders accordingly (opens in a new tab)
Jul 2015
- 9 Jul · Routine
  In respect of Company s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. July 09, 2015 to July 20, 2015 and will open on July 21, 2015 for insiders accordingly (opens in a new tab)